Back | Next |
home / stock / capr / capr message board
Subject | By | Source | When |
---|---|---|---|
Another DMD bio ticker SRPT is soaring to | Volcano | investorshub | 03/01/2023 2:41:22 PM |
BLA will be filed this summer | Volcano | investorshub | 02/24/2023 3:43:32 PM |
So where is the BLA | PARker1703 | investorshub | 02/23/2023 3:38:05 PM |
https://stocktwits.com/cninc/message/513117199 | Volcano | investorshub | 02/18/2023 6:41:42 PM |
$CAPR will be valued about $500 mil upon | Volcano | investorshub | 02/17/2023 3:04:06 AM |
$CAPR will be top gainer this year 1000% increase | Volcano | investorshub | 02/16/2023 10:43:31 PM |
https://stocktwits.com/Asher77/message/512803349 | Volcano | investorshub | 02/16/2023 10:01:21 PM |
$6 coming again This additional partnership by Nippon Shinyaku | Volcano | investorshub | 02/16/2023 3:43:56 PM |
what exactly does their 12 million buy... tough? | ed3/6me | investorshub | 02/16/2023 3:41:08 PM |
You bet The journey is just beginning Nippon Shinyaku | Volcano | investorshub | 02/16/2023 3:35:57 PM |
june or july. but the rise should start | ed3/6me | investorshub | 02/16/2023 3:33:26 PM |
Toru Nakai, President of Nippon Shinyaku, commented, We | Volcano | investorshub | 02/16/2023 3:23:30 PM |
Pps will keep going up now Huge ER in | Volcano | investorshub | 02/16/2023 3:22:05 PM |
Short squeeze is coming now | Volcano | investorshub | 02/16/2023 3:08:42 PM |
This additional partnership solidify FDA AA is coming | Volcano | investorshub | 02/16/2023 3:04:46 PM |
this should be the catalyst you have been | ed3/6me | investorshub | 02/16/2023 3:02:55 PM |
BLA submission coming very soon That is why NS | Volcano | investorshub | 02/16/2023 3:01:47 PM |
they must be very close!!! | ed3/6me | investorshub | 02/16/2023 2:57:37 PM |
Capricor Therapeutics and Nippon Shinyaku Enter Partnership for | Volcano | investorshub | 02/16/2023 2:36:04 PM |
21/01/23 $100 | peterus | investorshub | 02/03/2023 7:13:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Capricor Therapeutics Inc. Company Name:
CAPR Stock Symbol:
NASDAQ Market:
Capricor Therapeutics Inc. Website:
SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is set to join the Russell 2000 ® Index an...
-Results in Performance of the Upper Limb (PUL v2.0) Continue to Show Slowing of Disease Progression in Later-Stage DMD Patients- -Improvements Seen in Multiple Cardiac Endpoints Demonstrating Stabilization of Cardiac Function Over 3 Years of Treatment- -Pre-BLA Meeting with FDA...
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- In a release issued under the headline "Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy" on Tuesday, June 25th by Capricor Therapeutics, please note that the words "Pre-BLA Meeting with FDA for Deramiocel" were omitted ...